Replies to post #38000 on Ayala Pharmaceuticals Inc (ADXS)

[CATTDOGG12347]

Here’s another theory for you to think about. BMY owns cisplatin the drug we are being used as an adjuvant to in our P3. Now if results are coming out similar to our anal cancer trial and they should as the P3 has an extended dosing regimen, then I’m pretty sure BMY would have an Idea as to how well it’s doing.
Could this little nugget of information be what brought BMY in to do a combo trial with DUAL which was obviously designed explicitly for them to run a combo trial in end stage cervical cancer? I think the answer could very well be yes.